ACACA and lung cancer: ND-646, an allosteric inhibitor of ACC that prevents ACC dimerization and subsequently suppresses fatty acid synthesis, has shown efficacy in mouse models of lung cancer.112 TVB-2640 is a highly potent, selective, and reversible first-in-class inhibitor of FASN.